Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

Reparative functions of human airspace macrophage subsets

$6.03M USD

Funder NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
Recipient Organization National Jewish Health
Country United States
Start Date Jul 15, 2024
End Date Jun 30, 2029
Duration 1,811 days
Number of Grantees 1
Roles Principal Investigator
Data Source NIH (US)
Grant ID 10804314
Grant Description

PROJECT SUMMARY For lung health to be restored after inflammation, dead cells must be removed from the airspaces and the alveolar epithelium must be repaired. Airspace macrophages (AM) have been implicated in clearance of apoptotic cells, termed efferocytosis, and in orchestrating epithelial repair. Whether all AM are capable of these functions, or

whether distinct subsets perform specialized roles following inflammation is poorly understood. In previous studies, we leveraged an endobronchial lipopolysaccharide (LPS)-challenge model of acute lung inflammation in healthy adults to obtain human AM and investigate their transcriptional signatures. Using single cell RNA

sequencing, we discovered that after exposure to LPS, the airspaces are dominated by recruited AM. These recruited AM can be divided into two discrete subsets based, in part, on their efferocytic and reparative signatures. However, the causal mechanism by which efferocytosis is linked to reparative programing of AM in

humans has not been established. The primary objective of this proposal is to identify the unique functions and molecular drivers of AM subsets during resolution of inflammation and active lung repair. Based on analysis of transcriptional signatures and our prior studies, we postulate that a subset of AM that closely resemble interstitial

macrophages (imAM) are characterized by two unique functions. First, we propose that imAM are uniquely programed for efferocytosis. Second, we hypothesize that imAM drive repair of the alveolar epithelium through production of paracrine signaling molecules. The proposed studies will independently test the dependence of

efferocytosis on driving these functions. We will use primary AM obtained from endobronchial LPS-challenge of research participants and cutting-edge organotypic co-culture systems in the following three Specific Aims: 1) Test the hypothesis that imAM are specialized for efferocytosis. 2) Test the hypothesis that imAM promote

alveolar epithelial repair. 3) Determine whether efferocytosis is required for reparative programing of human AM.

All Grantees

National Jewish Health

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant